Effect of Ultrasound-guided Transversus Abdominis Plane Block With Compound Lidocaine and Esketamine on Postoperative Pain in Patients Undergoing Colorectal Cancer Surgery: a Randomized Double-blind Controlled Trial
Overview
- Phase
- N/A
- Intervention
- Normal saline
- Conditions
- Postoperative Pain
- Sponsor
- Tianjin Medical University General Hospital
- Enrollment
- 160
- Primary Endpoint
- Postoperative opioid consumption
- Last Updated
- 4 years ago
Overview
Brief Summary
Purpose:
To explore effects of ultrasound-guided transversus abdominis plane block with compound lidocaine and esketamine on postoperative pain after colorectal cancer surgery.
Detailed Description
Poor post-surgical pain control is a leading factor that hinders the physical rehabilitation, and causes acute cognitive impairment and chronic pain syndrome. Recently, the multimodal analgesia strategies to minimise opioid related side effects are highly desirable in open surgical procedures. The transversus abdominis plane block is a novel technique involving injection of local anaesthetic between the internal oblique and the transversus abdominis muscles of the abdominal wall. Although ropivacaine is most commonly used for this technique, the analgesic duration remains not dissatisfied. Compared with ropivacaine, compound lidocaine injection has a better and longer analgesic activity since it contains menthol and ethanol with appropriate concentrations. However, whether compound lidocaine injection is efficiency in the transversus abdominis plane block for abdominal surgery lacks investigations. Herein, we will evaluate the efficacy of ultrasound-guided transversus abdominis plane (USG-TAP) block with compound lidocaine injection and esketamine for postoperative analgesia in patients undergoing colorectal cancer surgery.
Investigators
Guolin Wang
Professor
Tianjin Medical University General Hospital
Eligibility Criteria
Inclusion Criteria
- •Subject is scheduled to undergo colorectal cancer surgery under general anesthesia
- •Subject's American Society of Anesthesiologists physical status is I-II.
- •The subject's parent/legally authorized guardian has given written informed consent to participate.
Exclusion Criteria
- •Subject has a diagnosis of bronchial asthma, coronary heart disease, severe hypertension, renal failure or liver failure.
- •Subject has a diagnosis of Insulin dependent diabetes.
- •Subject is allergy and contraindication to local anesthetics or any components of local anesthetics.
- •Subject has a history of chronic pain, a history of alcohol or opioid abuse, pre- existing therapy with opioids, intake of any analgesic drug within 48 hours before surgery.
- •Subject has any contraindication for the use of patient-controlled analgesia (PCA).
- •Subject is pregnant or breast-feeding.
- •Subject is obese (body mass index \>30kg/m\^2).
- •Subject is incapacity to comprehend pain assessment and cognitive assessment.
Arms & Interventions
Normal saline in transversus abdominis plane block
Before the induction of anesthesia, normal saline is used for bilateral transversus abdominis plane block in a volume of 20 mL of each side.
Intervention: Normal saline
Ropivacaine in transversus abdominis plane block
Before the induction of anesthesia, 0.375% ropivacaine is used for bilateral transversus abdominis plane block in a volume of 20 mL of each side.
Intervention: Ropivacaine
Compound lidocaine in transversus abdominis plane block
Before the induction of anesthesia, 0.4% compound lidocaine is used for bilateral transversus abdominis plane block in a volume of 20 mL of each side.
Intervention: Compound lidocaine
Compound lidocaine and esketamine in transversus abdominis plane block
Before the induction of anesthesia, 0.4% compound lidocaine and 0.4mg/kg esketamine are used for bilateral transversus abdominis plane block in a volume of 20 mL of each side.
Intervention: Compound lidocaine
Compound lidocaine and esketamine in transversus abdominis plane block
Before the induction of anesthesia, 0.4% compound lidocaine and 0.4mg/kg esketamine are used for bilateral transversus abdominis plane block in a volume of 20 mL of each side.
Intervention: Esketamine
Outcomes
Primary Outcomes
Postoperative opioid consumption
Time Frame: 48 hours after surgery
Each patient was administered analgesics using a PCA (Patient-controlled analgesia) pump containing opioid in normal saline after leaving PACU (Postanesthesia care unit). Opioid cumulative consumption is recorded for 48 hours postoperatively.
Secondary Outcomes
- Time of First Postoperative Analgesic Requirement(1 hour after surgery)
- Mean time until passage of flatus(96 hours after surgery)
- Diffusion area of local anesthetics after transversus abdominis plane block(30 minutes after transversus abdominis plane block)
- Pain Score (NRS)(48 hours after surgery)
- The level of cytokines in blood By ELISA kits(48 hours after surgery)
- The incidence of Side Effects(48 hours after surgery)
- Apfel score(The 1 day before the surgery)
- Normalized Area of Hyperalgesia Around the Incision(48 hours after surgery)
- Total Dose of First Postoperative Analgesic Requirement(1 hour after surgery)
- The level of chemokines in blood By ELISA kits(48 hours after surgery)